Further studies are needed to demonstrate this beneficial effect of olmesartan on adipose tissue oxidative stress and to clarify whether there is a functional role of adipose ATRAP in the pathophysiology of metabolic disorders. This evidence concerns the gene AGTRAP and metabolic disease.